2.0
11 Apr 2025
Former employee, more than 1 year
Eysins
Recommend
CEO approval
Business outlook
Pros
- interesting business (R&D, complex production, inventory management, commercialisation at early stage) - multi-cultural - diversity of staff
Cons
- business continuity at risk, inherent to biotech industry - understaffed in several departments, hence high workload